Haemonetics Corp (HAE)
84.44
+0.82
(+0.98%)
USD |
NYSE |
Apr 23, 10:29
Haemonetics Market Cap: 4.288B for April 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 22, 2024 | 4.247B |
| April 19, 2024 | 4.126B |
| April 18, 2024 | 4.239B |
| April 17, 2024 | 4.311B |
| April 16, 2024 | 4.275B |
| April 15, 2024 | 4.311B |
| April 12, 2024 | 4.328B |
| April 11, 2024 | 4.394B |
| April 10, 2024 | 4.375B |
| April 09, 2024 | 4.421B |
| April 08, 2024 | 4.333B |
| April 05, 2024 | 4.299B |
| April 04, 2024 | 4.311B |
| April 03, 2024 | 4.262B |
| April 02, 2024 | 4.275B |
| April 01, 2024 | 4.306B |
| March 28, 2024 | 4.335B |
| March 27, 2024 | 4.271B |
| March 26, 2024 | 4.146B |
| March 25, 2024 | 4.155B |
| March 22, 2024 | 4.077B |
| March 21, 2024 | 4.078B |
| March 20, 2024 | 4.054B |
| March 19, 2024 | 3.936B |
| March 18, 2024 | 3.849B |
| Date | Value |
|---|---|
| March 15, 2024 | 3.800B |
| March 14, 2024 | 3.839B |
| March 13, 2024 | 3.877B |
| March 12, 2024 | 3.904B |
| March 11, 2024 | 3.980B |
| March 08, 2024 | 4.043B |
| March 07, 2024 | 3.949B |
| March 06, 2024 | 3.933B |
| March 05, 2024 | 3.885B |
| March 04, 2024 | 3.798B |
| March 01, 2024 | 3.766B |
| February 29, 2024 | 3.706B |
| February 28, 2024 | 3.802B |
| February 27, 2024 | 3.772B |
| February 26, 2024 | 3.718B |
| February 23, 2024 | 3.733B |
| February 22, 2024 | 3.804B |
| February 21, 2024 | 3.721B |
| February 20, 2024 | 3.628B |
| February 16, 2024 | 3.675B |
| February 15, 2024 | 3.651B |
| February 14, 2024 | 3.618B |
| February 13, 2024 | 3.641B |
| February 12, 2024 | 3.797B |
| February 09, 2024 | 3.768B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.237B
Minimum
Jan 27 2022
7.089B
Maximum
Feb 08 2021
4.453B
Average
4.305B
Median
Market Cap Benchmarks
| Stryker Corp | 125.01B |
| Boston Scientific Corp | 100.36B |
| Insulet Corp | 11.74B |
| ResMed Inc | 27.05B |
| Masimo Corp | 7.242B |
Market Cap Related Metrics
| PE Ratio | 34.33 |
| PS Ratio | 3.414 |
| PEG Ratio | 1.041 |
| Price to Book Value | 4.546 |
| Price to Free Cash Flow | 33.68 |
| Price | 84.44 |
| Earnings Yield | 2.91% |
| PEGY Ratio | 1.041 |
| Operating PE Ratio | 24.06 |
| Normalized PE Ratio | 32.39 |